Opendata, web and dolomites
ASTELLAS PHARMA EUROPE BV (Netherlands): list of projects
The following table shows the list of Horizon 2020 projects developed by "ASTELLAS PHARMA EUROPE BV". Projects are ordered by starting date.
Click on table headers to rearrange data.
| # | acronym | programme | role | EC contrib. | start | views |
|---|---|---|---|---|---|---|
| 1 | BEAt-DKD | H2020-EU.3.1.7. | participant | 0.00 | 2016-09-01 | 1478 |
| 2 | PREFER | H2020-EU.3.1.7. | participant | 0.00 | 2016-10-01 | 664 |
| 3 | PIONEER | H2020-EU.3.1.7. | participant | 0.00 | 2018-05-01 | 612 |
| 4 | GetReal Initiative | H2020-EU.3.1.7. | participant | 0.00 | 2018-06-01 | 315 |
| 5 | MELLODDY | H2020-EU.3.1.7. | participant | 0.00 | 2019-06-01 | 408 |
| totale | 0.00 | |||||
Network analysis
This organization collaborated with partners in 15 countries.
BEAt-DKD
Within the project BEAt-DKD this organization got in touch with:
| role | cy | shortname | name |
|---|---|---|---|
| participant | US | JDRF | JDRF INTERNATIONAL (REC) |
| participant | US | AbbVie | ABBVIE INC (PRC) |
| participant | DE | Lipotype | LIPOTYPE (PRC) |
| participant | FI | UEF | ITA-SUOMEN YLIOPISTO (HES) |
| participant | UK | Eli Lilly | Eli Lilly and Company Limited (PRC) |
| participant | DE | SANOFI | SANOFI-AVENTIS DEUTSCHLAND GMBH (PRC) |
| participant | DE | Bayer | Bayer Pharma AG (PRC) |
| participant | DE | BI | BOEHRINGER INGELHEIM INTERNATIONALGMBH (PRC) |
| participant | FR | CHUB | CHU HOPITAUX DE BORDEAUX (HES) |
| participant | CH | SIB | SIB INSTITUT SUISSE DE BIOINFORMATIQUE (REC) |
| participant | IT | IRFMN | ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI (REC) |
| participant | IT | UBA | UNIVERSITA DEGLI STUDI DI BARI ALDO MORO (HES) |
| participant | US | UNIVERSITY OF MICHIGAN THE REGENTS OF THE UNIVERSITY OF MICHIGAN | UNIVERSITY OF MICHIGAN THE REGENTS OF THE UNIVERSITY OF MICHIGAN (HES) |
| participant | AT | MUI | MEDIZINISCHE UNIVERSITAT INNSBRUCK (HES) |
| participant | DE | UKE | UNIVERSITAETSKLINIKUM HAMBURG-EPPENDORF (HES) |
| participant | UK | UNEXE | THE UNIVERSITY OF EXETER (HES) |
| participant | DE | UKER | UNIVERSITATSKLINIKUM ERLANGEN (HES) |
| participant | DE | UKLFR | UNIVERSITAETSKLINIKUM FREIBURG (HES) |
| participant | DE | RCI | KLINIKUM DER UNIVERSITAET REGENSBURG (HES) |
| coordinator | SE | LU | LUNDS UNIVERSITET (HES) |
| participant | FI | UTU | TURUN YLIOPISTO (HES) |
| participant | UK | UHULL | UNIVERSITY OF HULL (HES) |
| participant | NL | UMCG | ACADEMISCH ZIEKENHUIS GRONINGEN (HES) |
| participant | DK | Novo Nordisk | NOVO NORDISK A/S (PRC) |
| participant | UK | UoB | UNIVERSITY OF BRISTOL (HES) |
| participant | UK | UNIVLEEDS | UNIVERSITY OF LEEDS (HES) |
| participant | UK | UNIVDUN | UNIVERSITY OF DUNDEE (HES) |
| participant | UK | UOXF | THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (HES) |
| participant | AT | MUW | MEDIZINISCHE UNIVERSITAET WIEN (HES) |
| participant | FI | UH | HELSINGIN YLIOPISTO (HES) |
PREFER
Within the project PREFER this organization got in touch with:
| role | cy | shortname | name |
|---|---|---|---|
| participant | DE | SPM | STEINBEISSER PROJECT MANAGEMENT UG (HAFTUNGSBESCHRANKT) (PRC) |
| participant | DE | CSL | CSL BEHRING GMBH (PRC) |
| participant | UK | MDUK | MUSCULAR DYSTROPHY GROUP OF GREAT BRITAIN AND NORTHERN IRELAND (OTH) |
| participant | BE | MB | MINDBYTES (PRC) |
| participant | UK | AbbVie | AbbVie Ltd (PRC) |
| participant | UK | IAPO | INTERNATIONAL ALLIANCE OF PATIENT'ORGANIZATIONS (OTH) |
| participant | UK | Amgen | AMGEN LIMITED (PRC) |
| participant | BE | KCE | FEDERAAL KENNISCENTRUM VOOR DE GEZONDHEIDSZORG (REC) |
| participant | UK | Takeda | TAKEDA DEVELOPMENT CENTRE EUROPE LTD (PRC) |
| participant | US | MSD | MERCK SHARP & DOHME CORP (PRC) |
| participant | BE | ECPC | EUROPEAN CANCER PATIENT COALITION (OTH) |
| participant | IT | ITB | "INSTITUTO TUMORI ""GIOVANNI PAOLO II""" (REC) |
| participant | UK | Lilly | Eli Lilly and Company Limited (PRC) |
| participant | DE | Bayer | Bayer Pharma AG (PRC) |
| participant | UK | Pfizer | PFIZER LIMITED (PRC) |
| participant | FR | SANOFI | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
| participant | BE | JP | JANSSEN PHARMACEUTICA NV (PRC) |
| participant | LU | EPF | FORUM EUROPEEN DES PATIENTS (FPE) (OTH) |
| participant | CH | ROCHE | F. HOFFMANN-LA ROCHE AG (PRC) |
| participant | CH | NVS | NOVARTIS PHARMA AG (PRC) |
| participant | CH | Actelion | ACTELION PHARMACEUTICALS LTD (PRC) |
| participant | NL | ERASMUS | ERASMUS UNIVERSITEIT ROTTERDAM (HES) |
| participant | DE | UKER | UNIVERSITATSKLINIKUM ERLANGEN (HES) |
| participant | UK | UoB | THE UNIVERSITY OF BIRMINGHAM (HES) |
| participant | NL | UMCU | UNIVERSITAIR MEDISCH CENTRUM UTRECHT (HES) |
| participant | SE | MEDIMMUNE | ASTRAZENECA AB (PRC) |
| participant | DE | Merck | MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN (PRC) |
| participant | IT | IEO | ISTITUTO EUROPEO DI ONCOLOGIA SRL (PRC) |
| coordinator | SE | UU | UPPSALA UNIVERSITET (HES) |
| participant | UK | UNEW | UNIVERSITY OF NEWCASTLE UPON TYNE (HES) |
| participant | NL | EMC | ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM (HES) |
| participant | BE | KUL | KATHOLIEKE UNIVERSITEIT LEUVEN (HES) |
PIONEER
Within the project PIONEER this organization got in touch with:
| role | cy | shortname | name |
|---|---|---|---|
| participant | FI | TUT | TAMPEREEN KORKEAKOULUSAATIO SR (HES) |
| participant | UK | eGF-eCancer | THE ECANCER GLOBAL FOUNDATION (OTH) |
| participant | FR | ASSOC EISBM | ASSOCIATION EISBM (REC) |
| coordinator | NL | EAU | STICHTING EUROPEAN UROLOGICAL FOUNDATION (OTH) |
| participant | UK | ICHOM | INTERNATIONAL CONSORTIUM FOR HEALTHOUTCOMES MEASUREMENT LTD (OTH) |
| participant | DE | Bayer AG | BAYER AKTIENGESELLSCHAFT (PRC) |
| participant | DE | VAR | VARIAN MEDICAL SYSTEM DEUTSCHLAND GMBH (PRC) |
| participant | SE | IHE | IHE, INSTITUTET FOR HALSO- OCH SJUKVARDSEKONOMI AKTIEBOLAG (PRC) |
| participant | BE | EAPM | EUROPEAN ALLIANCE FOR PERSONALISED MEDICINE ASBL (REC) |
| participant | UK | CI-eCancer | CANCER INTELLIGENCE LIMITED (PRC) |
| participant | BE | SAS | NV SAS INSTITUTE SA (PRC) |
| participant | UK | PM | PINSENT MASONS LLP (PRC) |
| participant | NL | TTOP | TTOPSTART BV (PRC) |
| participant | NL | The Hyve | THE HYVE BV (PRC) |
| participant | UK | IQVIA | IMS INFORMATION SOLUTIONS MEDICAL RESEARCH LIMITED (PRC) |
| participant | UK | COVANCE | COVANCE LABORATORIES LTD (PRC) |
| participant | BE | ECPC | EUROPEAN CANCER PATIENT COALITION (OTH) |
| participant | FR | SAN | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
| participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
| participant | BE | EORTC | EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL (REC) |
| participant | FI | ORION | ORION OYJ (PRC) |
| participant | IT | USR | UNIVERSITA VITA-SALUTE SAN RAFFAELE (HES) |
| participant | DE | UKE | UNIVERSITAETSKLINIKUM HAMBURG-EPPENDORF (HES) |
| participant | DE | TUD | TECHNISCHE UNIVERSITAET DRESDEN (HES) |
| participant | SE | LUND | LUNDS UNIVERSITET (HES) |
| participant | FI | UTA | TAMPEREEN YLIOPISTO (HES) |
| participant | UK | UoA | THE UNIVERSITY COURT OF THE UNIVERSITY OF ABERDEEN (HES) |
| participant | IL | WEIZMANN | WEIZMANN INSTITUTE OF SCIENCE (HES) |
| participant | UK | KCL | KING'S COLLEGE LONDON (HES) |
| participant | SE | UGOT-GGBC | GOETEBORGS UNIVERSITET (HES) |
| participant | DE | Fraunhofer | FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (REC) |
| participant | NL | Erasmus MC | ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM (HES) |
| participant | NL | SKU/RU | STICHTING KATHOLIEKE UNIVERSITEIT (HES) |
| participant | UK | Imperial | IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE (HES) |
GetReal Initiative
Within the project GetReal Initiative this organization got in touch with:
| role | cy | shortname | name |
|---|---|---|---|
| participant | DE | Bayer AG | BAYER AKTIENGESELLSCHAFT (PRC) |
| participant | BE | UCB | UCB BIOPHARMA SRL (PRC) |
| participant | UK | IAPO | INTERNATIONAL ALLIANCE OF PATIENT'ORGANIZATIONS (OTH) |
| participant | BE | VT | VITAL TRANSFORMATION (PRC) |
| participant | UK | Amgen | AMGEN LIMITED (PRC) |
| participant | NL | ZIN | ZORGINSTITUUT NEDERLAND (PUB) |
| participant | UK | TAKEDA | TAKEDA DEVELOPMENT CENTRE EUROPE LTD (PRC) |
| participant | UK | NICE | NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (PUB) |
| participant | FR | LA-SER | L.A SANTE, EPIDEMIOLOGIE, EVALUATION ET RECHERCHE L.A.S.E.R. (PRC) |
| participant | UK | Eli Lilly | Eli Lilly and Company Limited (PRC) |
| participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
| participant | NL | UMCG | ACADEMISCH ZIEKENHUIS GRONINGEN (HES) |
| coordinator | NL | UMCU | UNIVERSITAIR MEDISCH CENTRUM UTRECHT (HES) |
| participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
| participant | SE | MEDIMMUNE | ASTRAZENECA AB (PRC) |
MELLODDY
Within the project MELLODDY this organization got in touch with:
| role | cy | shortname | name |
|---|---|---|---|
| participant | DE | AmgenResMunich | AMGEN RESEARCH (MUNICH) GMBH (PRC) |
| participant | FR | Iktos | IKTOS (PRC) |
| participant | DE | Loodse GmbH | LOODSE GMBH (PRC) |
| participant | FR | SubstraF | SUBSTRA (OTH) |
| coordinator | FR | OWKIN | OWKIN FRANCE (PRC) |
| participant | DE | Bayer AG | BAYER AKTIENGESELLSCHAFT (PRC) |
| participant | CH | NVIDIA SWISS AG | NVIDIA SWITZERLAND AG (PRC) |
| participant | DE | BI | BOEHRINGER INGELHEIM INTERNATIONALGMBH (PRC) |
| participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
| participant | CH | NOVARTIS | NOVARTIS PHARMA AG (PRC) |
| participant | HU | BME | BUDAPESTI MUSZAKI ES GAZDASAGTUDOMANYI EGYETEM (HES) |
| participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
| participant | SE | MEDIMMUNE | ASTRAZENECA AB (PRC) |
| participant | FR | Servier | INSTITUT DE RECHERCHES SERVIER (PRC) |
| participant | DE | Merck | MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN (PRC) |
| participant | BE | KUL | KATHOLIEKE UNIVERSITEIT LEUVEN (HES) |